Eckert & Ziegler Sells Off The Non-Strategic Segment of Its Medical Robotics Business At Profit / Stock Buy Back Programm Approved

(Ad hoc press release)

Berlin, 27.09.2001. Eckert & Ziegler Strahlen- und Medizintechnik AG has sold the non-stragegic segment of its medical robotics business, which had been concentrated in the Berlin based company Jojumarie Intelligente Instrumente GmbH on Wednesday. The transaction resulted in a planned book profit of approximately 250,000 EUR. This sale will not affect the strategic positioning system used in the treatment of prostate cancer. This business unit has been integrated into the subsidiary BEBIG Isotopen- und Medizintechnik GmbH prior to the transaction.

In view of the historical lows of the share price, which in recent days have been partly below the book value of the total stockholder's equity, the Board will exercise its option of the authorization for a stock buy back programm up to a 100.000 EUR as of September 27, 2001. The stock buy back programm was authorized by the shareholders at the last annual shareholder meeting.

As previously announced Jürgen Ziegler, one of the original founding Board Members will vacate his position, Member of the Board, effective December 31, 2001, due to personal reasons. In anticipation of his departure the Board has decided to restructure the Berlin based radioactive source business. Nigel Talboys, the former Vice-President, Prostate Cancer Products, was appointed as the new General Manager for Sales and Marketing of BEBIG GmbH.

The Board of Directors